Clinical Study

Risk Factors Associated with Reoperation for Bleeding following Liver Transplantation

Table 3

Univariate and multivariable analysis of factors associated with reoperation for bleeding following liver transplantation.

VariableUnivariate analysisMultivariable analysis
Odds ratio95% CI valueOdds ratio95% CI value

Lab-MELD1.051.03, 1.08<0.00011.061.03, 1.09<0.0001
Surgical history0.930.42, 2.100.87
ICU Pre-LTx2.051.23, 3.150.006
WIT (Min)1.000.99, 1.010.48
OR length0.990.98, 1.000.13
DRI0.850.48, 1.520.58
pRBC1.040.99, 1.100.13
FFP1.090.99, 1.200.08
PLT0.870.76, 0.990.040.730.58, 0.910.004
Estrogen 0.670.41, 1.100.12
Aminocaproic acid0.590.34, 0.990.050.460.27, 0.800.006

MELD: Model for End-Stage Liver Disease; ICU: intensive care unit; LTx: liver transplantation; WIT: warm ischemia time; OR: operating room; DRI: donor risk index; pRBC: packed red blood cells; FFP: fresh frozen plasma; PLT: platelet; LTx: liver transplantation.